Results 41 to 50 of about 2,064 (201)

Ovarian adenosarcoma simulating a simple cyst in a young patient

Autopsy and Case Reports, 2014
Müllerian adenosarcoma is a rare, mixed tumor that can occur throughout the female genital tract, but is most commonly found in the uterus. Ovarian adenosarcoma is rarer and has a poorer prognosis than uterine adenosarcoma.
Leonardo Gomes da Fonseca, Aloisio Felipe-Silva, Samanta Cabral Severino da Silva, Paulo Francisco Ramos Margarido, Elias Abdo Filho, Paulo Marcelo Gehm Hoff   +5 more
doaj   +1 more source

Development and Validation of a Personalized Survival Prediction Model for Uterine Adenosarcoma: A Population-Based Deep Learning Study

Frontiers in Oncology, 2021
BackgroundThe aim was to develop a personalized survival prediction deep learning model for adenosarcoma patients using the surveillance, epidemiology and end results (SEER) database.MethodsA total of 797 uterine adenosarcoma patients were enrolled in ...
Wenjie Qu, Qingqing Liu, Xinlin Jiao, Teng Zhang, Bingyu Wang, Ningfeng Li, Taotao Dong, Baoxia Cui   +7 more
doaj   +1 more source

Adenosarcoma of the Nose [PDF]

the american journal of the medical sciences, 1906
n ...
openaire   +1 more source

Uterine mullerian adenosarcoma in very young patient

, 2020
Introduction: Uterine adenosarcoma mostly seen in elderly and there are limited data on appropriate approach in premenopausal patient and the accurate prognosis. Herein we aimed to present a young case of Mullerian adenosarcoma of uterus which had only 9
Allameh, Tajossadat, Naghshineh, Elham, Rajabi, Parvin, Mousavi Seresht, Leila, Izadi-Mood, Narges   +4 more
core   +1 more source

Mullerian Adenosaroma of the Cervix with Sarcomatous Overgrowth and Heterologous Elements Presenting as a Recurrent Cervical Polyp

Case Reports in Obstetrics and Gynecology, 2012
Mullerian adenosarcoma of the cervix is a rare tumor composed of benign epithelial and malignant stromal components. Sarcomatous overgrowth and heterologous elements in cervical adenosarcoma are extremely infrequent.
Slim Charfi, Rim Kallel, Hela Mnif, Sameh Ellouze, Mohamed Dhouib, Mohamed Guermazi, Abdelmajid Khabir, Tahya Sellami-Boudawara   +7 more
doaj   +1 more source

Imaging Description of Extragenital Müllerian Adenosarcoma: A Case Report [PDF]

Revista Brasileira de Ginecologia e Obstetrícia
Müllerian adenosarcoma is a very rare gynecological disease, comprising 5% of uterine sarcomas. Extragenital localizations are even rarer.We report a very interesting case of a 27-year-old woman complaining of pelvic pain, with a subsequent diagnosis of ...
Annalisa Mone, Piergiorgio Iannone
doaj   +2 more sources

The immune microenvironment of uterine adenosarcomas [PDF]

Clinical Sarcoma Research, 2020
Abstract Background Uterine adenosarcoma (UA) is an extremely rare sarcoma subtype. There has been limited evaluation of the immune microenvironment in these tumors. The objective of this study is to examine and describe the immune infiltrate and PD-1/PD-L1 expression in UA and to correlate these changes in the tumor ...
Ali, Ali Mohammed Refaat, Tsai, Jen-Wei, Leung, Cheuk Hong, Lin, Heather, Ravi, Vinod, Conley, Anthony P., Lazar, Alexander J., Wang, Wei-Lien, Nathenson, Michael J.   +8 more
openaire   +2 more sources

Adenosarcoma of uterus in mother and mucinous carcinoma of breast in daughter: a rare case study [PDF]

, 2023
Adenosarcoma is an infrequent malignancy which consists of benign glandular epithelium and malignant mesenchymal component. We report a 63-year-old woman diagnosed with adenosarcoma with sarcomatous overgrowth of the uterine corpus, with history of ...
Reddy, Samskruthi S., Nagesh, Kavya, V., Shashikala, Prasad, Madhva, Girigoudar, Arpita, Modugala, Vandana   +5 more
core   +1 more source

Microsatellite Instability Status and the Expression of p16 and Cyclin D1 Proteins in Uterine Adenosarcoma and Their Clinicopathological Significance

Türk Patoloji Dergisi, 2023
Objective: Uterine adenosarcoma has low malignant potential, except in cases with sarcomatous overgrowth (SOG) and a high-grade morphology. We here point out the prognostic clinicopathological and immunohistochemical features as well as the ...
Alev OK ATILGAN, Eda YILMAZ AKCAY, Ozlem OZEN, A. Nihan HABERAL REYHAN, Ali AYHAN   +4 more
doaj   +1 more source

Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report

Current Oncology, 2021
A 32-year-old woman with chemorefractory mullerian adenosarcoma showed clinical benefit in response to administration of lenvatinib plus pembrolizumab. In this case report, we describe the course of her illness and her response to this treatment.
Thierry Alcindor, Sungmi Jung, Lucy Gilbert   +2 more
doaj   +1 more source